Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IQVIA HOLDINGS INC.

(IQV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

IQVIA : Morgan Stanley Adjusts Price Target on IQVIA Holdings to $290 from $280, Keeps Overweight Rating

10/22/2021 | 10:50am EST


ę MT Newswires 2021
All news about IQVIA HOLDINGS INC.
12/02IQVIA Decentralized Trial Suite Launches Mobile Research Nursing and Phlebotomy Service..
BU
12/02IQVIA Decentralized Trial Suite Launches Mobile Research Nursing and Phlebotomy Service..
CI
12/02INSIDER SELL : Iqvia Holdings
MT
12/01Teva Launches Epiduo Forte Gel's Generic Version in US
MT
12/01IQVIA Recognized as a Leader in BPO Solutions for Pharmaceutical Sales and Marketing
BU
11/19Amneal Pharmaceuticals Obtains FDA Approval for Difluprednate Ophthalmic Emulsion
MT
11/18IQVIA Launches New Grants/Funding Management Module for Its Orchestrated Customer Engag..
CI
11/18IQVIA Launches New Grants/Funding Management Module for Its Orchestrated Customer Engag..
BU
11/18Mizuho Securities Adjusts IQVIA Holdings' Price Target to $290 From $282, Reiterates Bu..
MT
11/18Piper Sandler Adjusts Price Target on IQVIA Holdings to $261 From $250, Maintains Neutr..
MT
More news
Analyst Recommendations on IQVIA HOLDINGS INC.
More recommendations
Financials (USD)
Sales 2021 13 830 M - -
Net income 2021 922 M - -
Net Debt 2021 10 634 M - -
P/E ratio 2021 55,3x
Yield 2021 -
Capitalization 49 991 M 49 991 M -
EV / Sales 2021 4,38x
EV / Sales 2022 4,00x
Nbr of Employees 77 000
Free-Float 74,2%
Chart IQVIA HOLDINGS INC.
Duration : Period :
IQVIA Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Last Close Price 261,68 $
Average target price 300,29 $
Spread / Average Target 14,8%
EPS Revisions
Managers and Directors
Ari Bousbib Chairman, President & Chief Executive Officer
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
W. Richard Staub President-Research & Development Solutions
Kevin C. Knightly President-Technology & Commercial Solutions
Sector and Competitors
1st jan.Capi. (M$)
IQVIA HOLDINGS INC.46.05%49 991
MODERNA, INC.193.60%124 359
LONZA GROUP AG25.98%58 058
SEAGEN INC.-13.93%27 564
CELLTRION, INC.-41.36%24 298
ICON PUBLIC LIMITED COMPANY39.92%22 206